bromocriptine has been researched along with lysergic acid diethylamide in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anlezark, G; Meldrum, B | 1 |
| Asper, H; Bürki, HR; Ruch, W; Züger, PE | 1 |
| Anlezark, GM; Horton, RW; Meldrum, BS | 1 |
| Horowski, R | 1 |
| Gonzalez-Lima, F; Hart, WT; Rivera-Quinones, C | 1 |
| Hruska, RE; Silbergeld, EK | 1 |
| Cheng, CY; Giacomelli, S; Palmery, M; Romanelli, L; Silvestrini, B | 1 |
| Lee, MR | 1 |
8 other study(ies) available for bromocriptine and lysergic acid diethylamide
| Article | Year |
|---|---|
Blockade of photically induced epilepsy by 'dopamine agonist' ergot alkaloids.
Topics: Allyl Compounds; Animals; Bromocriptine; Dopamine; Electroencephalography; Epilepsy; Ergolines; Ergonovine; Ergot Alkaloids; Haplorhini; Lysergic Acid Diethylamide; Papio; Photic Stimulation | 1978 |
Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF25--397, and 29--712: effects on the metabolism of the biogenic amines in the brain of the rat.
Topics: Animals; Biogenic Amines; Brain; Bromocriptine; Dihydroergotoxine; Dopamine; Ergolines; Lysergic Acid Diethylamide; Male; Methysergide; Nitriles; Pyridines; Rats; Receptors, Drug; Reserpine; Serotonin | 1978 |
Dopamine agonists and audiogenic seizures: the relationship between protection against seizures and changes in monoamine metabolism.
Topics: Acoustic Stimulation; Animals; Apomorphine; Biogenic Amines; Brain; Bromocriptine; Dopamine; Ergolines; Ergonovine; Female; Lysergic Acid Diethylamide; Male; Mice; Mice, Inbred DBA; Quipazine; Seizures | 1978 |
Differences in the dopaminergic effects of the ergot derivatives bromocriptine, lisuride and d-LSD as compared with apomorphine.
Topics: Animals; Apomorphine; Body Temperature; Bromocriptine; Dopamine; Drug Interactions; Ergot Alkaloids; Female; Lisuride; Lysergic Acid Diethylamide; Methyltyrosines; Mice; Reserpine; Sulpiride | 1978 |
Metabolite involvement in the behavioral effects of bromocriptine in cats.
Topics: Animals; Behavior, Animal; Bromocriptine; Cats; Female; Lysergic Acid Diethylamide; Male; Proadifen; Propylene Glycols | 1987 |
Inhibition of neurotransmitter receptor binding by ergot derivatives.
Topics: Adrenergic alpha-Antagonists; Animals; Brain; Bromocriptine; Dioxanes; Ergolines; Ergot Alkaloids; gamma-Aminobutyric Acid; Lysergic Acid Diethylamide; Male; Metergoline; Organ Specificity; Quinuclidinyl Benzilate; Rats; Receptors, Neurotransmitter; Serotonin; Spiperone; Structure-Activity Relationship; Synapses | 1981 |
Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Cells, Cultured; Cyproheptadine; Dopamine; Dopamine Agonists; Dopamine Antagonists; Female; Lysergic Acid Diethylamide; Pituitary Gland; Prolactin; Rats; Rats, Wistar; Receptors, Dopamine D2 | 1998 |
The history of ergot of rye (Claviceps purpurea) III: 1940-80.
Topics: Bromocriptine; Claviceps; Dihydroergocryptine; Ergot Alkaloids; History, 20th Century; Humans; Lysergic Acid Diethylamide; Parkinson Disease; Prolactinoma; Receptors, Dopamine; Schizophrenia; Scotland; Secale | 2010 |